Form 4: Stryker VP Granted 1,830 Stock Options

Stryker Corporation's VP, Chief Communications Officer, Kimberly Ann Montagnino, was granted 1,830 employee stock options with an exercise price of $360.82.

Summary

• Kimberly Ann Montagnino, VP, Chief Communications Officer of Stryker Corp (SYK), was granted 1,830 employee stock options.
• The options were granted on February 4, 2026, under the Stryker Corporation 2011 Long-Term Incentive Plan.
• Each option has an exercise price of $360.82 and allows the holder to purchase one share of Stryker Common Stock.
• The options become exercisable as to 20% on each of the first five anniversaries of the grant date.
• The options have an expiration date of February 3, 2036.
• Following this transaction, Montagnino beneficially owns 1,830 derivative securities.
• A Power of Attorney, dated August 26, 2025, authorizes specific individuals, including Austin Y. Ke, to file SEC documents on Montagnino's behalf.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine and generally positive corporate governance action, aligning executive incentives with long-term shareholder value, without indicating any immediate operational or financial changes.

Positives

• Granting of stock options aligns management incentives with shareholder interests, encouraging long-term performance.
• The options are part of the Stryker Corporation 2011 Long-Term Incentive Plan, indicating a structured approach to executive compensation.

Risks

• The value of the stock options is tied to the future performance of Stryker's common stock; if the stock price does not exceed the exercise price, the options may expire worthless.
• Dilution risk for existing shareholders if a significant number of options are exercised, though this grant of 1,830 options is minor in the context of a large public company.

Future Outlook

This filing primarily reports a past transaction (grant of options) with future exercisability. It indicates a continued commitment to long-term incentive plans for executives. The options will become exercisable over the next five years, starting from February 4, 2026.

Management Comments

• Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.

Industry Context

StockSavvy.ai notes that granting stock options to key executives like a VP, Chief Communications Officer, is a standard practice in large, publicly traded medical technology companies such as Stryker. This aligns executive compensation with shareholder value creation over the long term, a common strategy to retain talent and incentivize performance in competitive industries.

Comparison to Industry Standards

• The grant of stock options as part of a long-term incentive plan is a common compensation structure for executives in the medical technology sector, similar to practices at peers like Medtronic (MDT) or Johnson & Johnson (JNJ).
• The vesting schedule of 20% over five years is a typical approach to ensure executive retention and align incentives with sustained company performance, comparable to similar plans observed at other large-cap companies.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased alignment of executive interests with shareholder value creation; minor potential for future dilution upon exercise of options.
• Employees: Reflects the company's compensation strategy for senior leadership, potentially influencing broader employee incentive programs.

Next Steps

• The options will become exercisable as to 20% on each of the first five anniversaries of the grant date (February 4, 2026).
• Kimberly Ann Montagnino will continue to be subject to Section 16 filing requirements for future transactions in Stryker securities.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (stock option grant) and does not contain information that would fundamentally alter the investment thesis for Stryker. It reinforces the company's standard practice of aligning executive incentives with long-term performance, which is generally a neutral to slightly positive factor. Therefore, a "hold" recommendation is appropriate as this filing alone does not provide a basis for a "buy" or "sell" decision.

Keywords

Stryker, SYK, Stock Options, Executive Compensation, Form 4, Insider Transaction, Long-Term Incentive Plan, Kimberly Ann Montagnino